✦ LIBER ✦

IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?

✍ Scribed by Tomasz A. Swierkosz; Nicholas Valettas; Howard C. Herrmann

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 27 KB
Volume: 52
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.1097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

“IIb or Not IIb or Maybe IIb?” Is that t

“IIb or Not IIb or Maybe IIb?” Is that the question? Or is it “Which IIb and to Whom?”

✍ Jeffrey A. Brinker 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Distal myocardial protection with intrac

Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome

✍ Barry F. Uretsky; Yochai Birnbaum; Abdulfatah Osman; Rajiv Gupta; Oscar Paniagua 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Impact of diabetes on long-term outcome

Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors and BMS or DES

✍ Giuseppe De Luca; Rosario Sauro; Attilio Varricchio; Michele Capasso; Tonino Lan 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 486 KB

Efficacy and safety of argatroban with o

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

✍ Ignacio Cruz-Gonzalez; Maria Sanchez-Ledesma; Suzanne J. Baron; Josephine L. Hea 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 138 KB